0001209191-17-041038.txt : 20170620 0001209191-17-041038.hdr.sgml : 20170620 20170620145244 ACCESSION NUMBER: 0001209191-17-041038 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170614 FILED AS OF DATE: 20170620 DATE AS OF CHANGE: 20170620 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Eiger BioPharmaceuticals, Inc. CENTRAL INDEX KEY: 0001305253 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 361004130 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 350 CAMBRIDGE AVE STREET 2: SUITE 350 CITY: PALO ALTO STATE: CA ZIP: 94306 BUSINESS PHONE: 650-279-9845 MAIL ADDRESS: STREET 1: 350 CAMBRIDGE AVE STREET 2: SUITE 350 CITY: PALO ALTO STATE: CA ZIP: 94306 FORMER COMPANY: FORMER CONFORMED NAME: Celladon Corp DATE OF NAME CHANGE: 20041005 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Apelian David CENTRAL INDEX KEY: 0001546842 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36183 FILM NUMBER: 17920632 MAIL ADDRESS: STREET 1: C/O ACHILLION PHARMACEUTICALS, INC STREET 2: 300 GEORGE STREET CITY: NEW HAVEN STATE: CT ZIP: 06511 3 1 doc3.xml FORM 3 SUBMISSION X0206 3 2017-06-14 1 0001305253 Eiger BioPharmaceuticals, Inc. EIGR 0001546842 Apelian David 350 CAMBRIDGE AVE #350 PALO ALTO CA 94306 1 0 0 0 No securities are beneficially owned. /s/ David Apelian 2017-06-14